The Latest Breaking News from Abbott

Abbott stock climbed Wednesday as it reported quarterly results that beat estimates, driven by $3.3 billion in sales of its Covid-19 tests.

Abbott Laboratories (NYSE:ABT) has reported Q1 FY22 adjusted EPS of $1.73, up 31.1% Y/Y, better than the consensus of $1.47 and the management guidance of $1.50. Q1 sales of $11.9 billion increased 13.8% on a reported basis and 17.5% on an organic basis, beating the consensus of $11.02 billion. Worldwide sales, excluding…

Federal safety inspectors say baby formula maker Abbott failed to maintain sanitary conditions at the Michigan manufacturing plant recently linked to a cluster of infant illnesses

LOS ANGELES — ABC, the home of freshman comedy "Abbott Elementary," has partnered with publishing company Scholastic to provide underfunded schools with free book fairs, coupling the successful show's marketing campaign with a very worthy cause.

The Food Standards Agency has identified products not mentioned on the label or with salmonella

FDA and CDC urge parents to avoid feeding babies formula produced at Michigan facility operated by Abbott Nutrition

Parents who bought recalled infant formulas made by Abbott Laboratories are filing proposed class-action lawsuits against Abbott, as the U.S. Food and Drug Administration investigates reports of three babies who became sick and two who died after consuming the formulas.

Anyone who has purchased these products are being urged not to consume them. Supermarkets Waitrose and Tesco along with manufacturer Abbott are affected.

The two pathogens can cause serious illness in young and vulnerable children, including sepsis and meningitis